The road to refractory graft-versus-host disease is paved with good intentions
Refractory acute graft-versus-host disease (GVHD) occurs when the immune injury exceeds the capacity of injured tissues to regenerate and repair. While glucocorticoids have been used for decades to treat GVHD, Arnhold, Chang, and colleagues in this issue of the JCI question whether this approach can...
| Published in: | The Journal of Clinical Investigation |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
American Society for Clinical Investigation
2024-04-01
|
| Online Access: | https://doi.org/10.1172/JCI177728 |